IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

Facing stubborn manufacturing challenges

September 16, 2024

Manufacturing proteins is notoriously expensive and complex. Will new ways of producing them come from continuous processes, Sunflowers, or even…goat milk?

Read more

IAVI Report

Another inflection point in the HIV/AIDS response

July 31, 2024

Last week at AIDS 2024 many experts warned that the global response is at a critical inflection point. Will efforts to develop and provide access to new prevention options drive much-needed progress?

Read more

IAVI Report

The ties that bind

July 23, 2024

Assessing two decades of a European-African research partnership with an anxious eye on the future.

Read more

IAVI Report

Building better B cells: An interview with James Voss

June 18, 2024

Voss and his team are using gene editing technologies to reprogram B cells to make broadly neutralizing antibodies against HIV. Will this be a route to a functional cure?

Read more

IAVI Report

Will monoclonal antibodies be a new weapon in the fight against malaria?

May 20, 2024

Recent data suggest these engineered proteins can prevent the parasitic infection, but cost will ultimately determine if they are made available in low- and middle-income countries where they are needed most.

Read more

IAVI Report

Rethinking antibodies for infectious diseases?

April 23, 2024

The COVID-19 experience, along with lingering manufacturing and delivery concerns, is prompting a harder look at the future of antibody-based treatment and prevention for infectious diseases.

Read more

IAVI Report

Don’t Stop Believin’: This year’s HIV vaccine research theme

March 14, 2024

Researchers at CROI discuss progress on the long road to developing an HIV vaccine.

Read more

IAVI Report

With syphilis, it’s yesterday once more

March 14, 2024

Infections are at the highest levels since 1950 and fear of antimicrobial resistance is fueling new concerns over this old pathogen.

Read more

IAVI Report

Upending the dogma of TB latency: Will it offer new clues for vaccine research?

February 14, 2024

Nearly 150 years after the discovery of tuberculosis, researchers are still unraveling the fundamental biology and epidemiology of the germ and how best to defeat it.

Read more

IAVI Report

Will AI crack the code for antigens?

November 30, 2023

The scientific implications of artificial intelligence loom large. One tangible application is designing better vaccines.

Read more

IAVI Report

Marion Gruber, Changemaker

November 9, 2023

After more than three decades at the U.S. Food and Drug Administration, Gruber is continuing her legacy of changing the way vaccines are licensed and distributed.

Read more

IAVI Report

Painstaking progress in African vaccine manufacturing

October 31, 2023

Improving vaccine access topped the agenda at a major public health gathering in Berlin, where pandemic preparedness loomed large.

Read more